Eugene
Making proactive healthcare the new normal.
Making proactive healthcare the new normal.
Eugene is a digital healthcare company founded in 2017 in Melbourne, Australia, with a mission to make proactive healthcare the new normal. The company offers the first medical grade at-home genetic testing and counselling service to individuals in Australia and New Zealand. Their non-invasive, salvia-based tests are highly effective and are accompanied by ongoing support from in-house genetic counsellors. Their approach eliminates waiting rooms, referrals, and blood tests, providing best-in-class clinical care that is easily accessible. Eugene caters to various health needs including preconception, pregnancy, cancer, and heart health. Their recent Series A investment of $1.00M on 01 October 2022 was secured from ALIAVIA Ventures.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $1.00M | 1 |
|
01 Oct 2022 |
| Series A | $649.00K | 2 |
|
01 Oct 2021 |
| Seed Round | Unknown | 3 |
|
25 Feb 2020 |
No recent news or press coverage available for Eugene.
We care about your data, and we'd love to use cookies make your experience better.
